Ursprung des Netzwerks ersten Grades von Georg Floß
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
26
| Public Company | Pharmaceuticals: Other | 26 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Georg Floß
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
BPC Plasma, Inc.
 BPC Plasma, Inc. Pharmaceuticals: MajorHealth Technology BPC Plasma, Inc. manufactures pharmaceutical products. It offers the hyper immunoglobulin Nabi-HB, a key product used in the prevention of hepatitis B. The company was established in 2007 and is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | Director/Board Member Chairman Director/Board Member Director/Board Member | |
| MERCK KGAA | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member Corporate Officer/Principal | |
BASF Pharma Ltd.
 BASF Pharma Ltd. Pharmaceuticals: MajorHealth Technology Part of Abbott Laboratories, BASF Pharma Ltd. is a British company that produces excipients and active ingredients. The company is based in Kent, UK. The company was founded by Erich Schlick. BASF Pharma was acquired by Abbott Laboratories from BASF SE on March 02, 2001 for $6,128.79 million. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services The Plasma Protein Therapeutics Association is a non-profit organization that represents manufacturers and plasma collection centers. The private company is based in Washington and has subsidiaries in the United States. Anita Brikman has been the CEO of the American company since 2023. | Miscellaneous Commercial Services | Director/Board Member Director/Board Member | |
| Ruprecht-Karls-Universität Heidelberg | College/University | Director/Board Member Undergraduate Degree | |
Boehringer Ingelheim GmbH
 Boehringer Ingelheim GmbH Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim GmbH engages in the provision of central management and other services for the group companies on behalf of C.H. Boehringer Sohn AG & Co. KG. The group specializes in the development, production, and distribution of pharmaceutical products. The company was founded in 1885 and is headquartered in Ingelheim am Rhein, Germany. | Pharmaceuticals: Major | Chairman Director of Finance/CFO | |
| Universität zu Köln | College/University | Doctorate Degree Graduate Degree | |
| GRIFOLS, S.A. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
Tiancheng (Germany) Pharmaceutical Holdings AG
 Tiancheng (Germany) Pharmaceutical Holdings AG Pharmaceuticals: MajorHealth Technology Part of Grifols SA, Tiancheng (Germany) Pharmaceutical Holdings AG is a pharmaceutical company that manufactures pharmaceutical products. The company is based in Dusseldorf, Germany. The company was founded in 2017. Tiancheng (Germany) Pharmaceutical Holdings was acquired by Grifols SA from Creat Group Co., Ltd. on April 25, 2022 for $1,273.64 million. | Pharmaceuticals: Major | Corporate Officer/Principal Director/Board Member | |
Bio Products Laboratory Ltd.
 Bio Products Laboratory Ltd. Pharmaceuticals: MajorHealth Technology Bio Products Laboratory Ltd. manufactures blood plasma products. It offers products that are classified in human coagulation factors, human immunoglobulins, and human albumin solutions. The company was founded on August 11, 1950 and is headquartered in Elstree, the United Kingdom. | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
Biotest Pharma GmbH
 Biotest Pharma GmbH Pharmaceuticals: OtherHealth Technology Biotest Pharma GmbH engages in the manufacture and distribution of medicinal and pharmaceutical products. The company is headquartered in Dreieich, Germany. | Pharmaceuticals: Other | Chief Executive Officer Chief Executive Officer | |
Grifols USA, Inc.
 Grifols USA, Inc. Medical SpecialtiesHealth Technology Grifols USA, Inc. sales and markets automated analyzers and dosing machines. The company supplies plasma products, diagnostic reagents, analyzers and dosing machines. Grifols USA was founded in 1948 and is headquartered in Los Angeles, CA. | Medical Specialties | Director/Board Member General Counsel | |
| AFFIMED N.V. | Biotechnology | Director/Board Member Director/Board Member | |
| SHANGHAI RAAS BLOOD PRODUCTS CO., LTD. | Biotechnology | Director/Board Member Director/Board Member | |
Grifols Innovation & New Technologies Ltd.
 Grifols Innovation & New Technologies Ltd. BiotechnologyHealth Technology Grifols Innovation & New Technologies Ltd. provides research and experimental development services in biotechnology sector. The company was founded on December 21, 2015 and is headquartered in Dublin, Ireland. | Biotechnology | Director/Board Member Chief Executive Officer | |
| Ludwig-Maximilians-Universität München | College/University | Undergraduate Degree Undergraduate Degree | |
Biomat USA, Inc.
 Biomat USA, Inc. Medical/Nursing ServicesHealth Services Biomat USA, Inc. provides plasma derived blood products. The company is headquartered in Los Angeles, CA. | Medical/Nursing Services | Director/Board Member Chief Executive Officer | |
Alkahest, Inc.
 Alkahest, Inc. BiotechnologyHealth Technology Alkahest, Inc. operates as biopharmaceutical company. It focuses on developing of treatments for neurodegenerative and age-related diseases. The company is headquartered in San Carlos, CA. | Biotechnology | Director/Board Member Director/Board Member | |
Grifols, Inc.
 Grifols, Inc. Pharmaceuticals: MajorHealth Technology Grifols, Inc. manufactures pharmaceuticals. The company is headquartered in Los Angeles, CA. | Pharmaceuticals: Major | Chief Operating Officer | |
| University of California, Irvine | College/University | Undergraduate Degree | |
Knapp, Petersen & Clarke PC
 Knapp, Petersen & Clarke PC Miscellaneous Commercial ServicesCommercial Services Knapp, Petersen & Clarke PC is a law firm that offers a variety of legal services. The private company is based in Glendale, CA. The firm emphasizes its creativity and accessibility in providing these services. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Alpha Therapeutic Corp.
 Alpha Therapeutic Corp. BiotechnologyHealth Technology Part of Grifols SA/Grifols Family/, Alpha Therapeutic Corp. develops plasma derived products. The company is based in Los Angeles, CA. | Biotechnology | General Counsel | |
Singulex, Inc.
 Singulex, Inc. Miscellaneous Commercial ServicesCommercial Services Singulex, Inc. provides biotechnological research and development services. It also provides instrumentation and immunoassays with the requisite sensitivity and specificity to enable biomarker discovery and validation for drug safety and efficacy. The company was founded by Robert S. Puskas in November 1997 and is headquartered in Alameda, CA. | Miscellaneous Commercial Services | Director/Board Member | |
GigaGen, Inc.
 GigaGen, Inc. BiotechnologyHealth Technology GigaGen, Inc. engages in the provision of single cell droplet technology to clinical researchers and physicians. The firm's patent-pending technology combines microfluidics, next-generation sequencing, and bioinformatics to digitize genetic data from cells circulating in blood. Its technology can be applied in immunology, infectious disease monitoring, noninvasive prenatal diagnostics, and noninvasive cancer detection. The company was founded by David S. Johnson and Everett Meyer in 2010 and is headquartered in South San Francisco, CA. | Biotechnology | Director/Board Member | |
| Southwestern Law School | College/University | Graduate Degree | |
VCN Biosciences SL
 VCN Biosciences SL Miscellaneous Commercial ServicesCommercial Services Part of Theriva Biologics, Inc., VCN Biosciences SL is a clinical-stage immuno-oncology company based in Barcelona, Spain. The Spanish company focuses on developing the next generation of oncolytic adenoviruses that can obtain clinical activity after systemic administration and remodel the complex matrix in the tumor to allow enhanced spreading of therapeutic molecules and the immune system. VCN Biosciences' lead product, VCN-01, is a unique oncolytic adenovirus being studied in clinical trials for cancers for which there is no cure, including pancreatic carcinoma and retinoblastoma. The company was founded by Ramon Alemany. VCN Biosciences was acquired by Theriva Biologics, Inc. from Grifols SA on March 10, 2022 for $92.02 million. | Miscellaneous Commercial Services | Director/Board Member | |
| Harvard Law School | College/University | Graduate Degree | |
| Scripps Clinic & Research Foundation | Corporate Officer/Principal | ||
American Association for Cancer Research
 American Association for Cancer Research Miscellaneous Commercial ServicesCommercial Services American Association for Cancer Research prints and publishes scientific journals including clinical cancer research, molecular cancer therapeutics, molecular cancer research, cancer epidemiology, and biomarkers and prevention. The company was founded on May 7, 1907 and is headquartered in Philadelphia, PA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
Neovii Biotech GmbH
 Neovii Biotech GmbH BiotechnologyHealth Technology Neovii Biotech GmbH develops and markets biopharmaceutical products in the field of transplantation. The company was founded in 2003 and is headquartered in Gräfelfing, Germany. | Biotechnology | Chief Executive Officer | |
| ADMA BIOLOGICS, INC. | Biotechnology | Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Chairman | |
Affimed GmbH
 Affimed GmbH Miscellaneous Commercial ServicesCommercial Services Part of Affimed NV, Affimed GmbH is a clinical leader in innate immuno-oncology. The company, based in Heidelberg, Germany, develops proprietary cancer-targeting bispecific antibodies that activate the innate immune system to kill tumor cells. Affimed leads clinical development of innate cell engagers for solid/hematologic tumors as monotherapy, in combination with NK cells or with checkpoint inhibitors. Adolf Hoess has been the CEO of the German company since 2010. | Miscellaneous Commercial Services | Director/Board Member | |
| ACHILLES THERAPEUTICS PLC | Pharmaceuticals: Major | Director/Board Member | |
Merck Serono SA
 Merck Serono SA Medical SpecialtiesHealth Technology Merck Serono SA operates as a holding company in the pharmaceutical field. It engages in the research, development, manufacture, and distribution of therapeutic products for the treatment of human diseases. The company was founded on May 21, 1987 and is headquartered in Coinsins, Switzerland. | Medical Specialties | Public Communications Contact | |
Sartorius CellGenix GmbH
 Sartorius CellGenix GmbH BiotechnologyHealth Technology CellGenix GmbH provides biopharmaceutical products. Its products include CellGro Cytokines, CellGro Supplements and Cells, Bioprocessing Containers and CellGro Serum-free Media. It is supplier of GMP (Good Manufacturing Practice) manufactured cytokines and serum-free media for cell therapy applications. The company was founded in 1994 and is headquartered in Freiburg, Germany. | Biotechnology | Corporate Officer/Principal | |
| University of Giessen | College/University | Corporate Officer/Principal | |
E. Merck KG
 E. Merck KG Pharmaceuticals: MajorHealth Technology E. Merck KG operates as a holding company with interest in pharmaceutical preparations. It acts as a general partner that holds the majority of shares of the public company Merck KGaA. Merck KG is the parent company of all Merck companies yet it does not have any operating businesses itself. It makes the entrepreneurial policy decisions for the Merck Group. The company is headquartered in Darmstadt, Germany. | Pharmaceuticals: Major | Director/Board Member | |
Biotest US Corp.
 Biotest US Corp. Pharmaceuticals: MajorHealth Technology Biotest US Corp. manufactures pharmaceutical products. The company is headquartered in Boca Raton, FL. | Pharmaceuticals: Major | President | |
Biotest (U.K.) Ltd.
 Biotest (U.K.) Ltd. Pharmaceuticals: MajorHealth Technology Part of Grifols SA, Biotest (U.K.) Ltd. is a British company that supplies plasma protein products and biotherapeutic drugs. The company is based in Longbridge, UK. Our products are primarily used in the therapeutic areas of clinical immunology, haematology and intensive care medicine. Wayne Mullins has been the CEO of the company since 2013. | Pharmaceuticals: Major | Director/Board Member | |
| Biotest Seralc NV/SA | Director/Board Member |
Statistik
International
| Vereinigte Staaten | 24 |
| Deutschland | 17 |
| Vereinigtes Königreich | 5 |
| Spanien | 3 |
| China | 2 |
Sektoral
| Health Technology | 31 |
| Commercial Services | 8 |
| Consumer Services | 8 |
| Health Services | 2 |
| Distribution Services | 2 |
Operativ
| Director/Board Member | 110 |
| Corporate Officer/Principal | 46 |
| Chief Executive Officer | 32 |
| Chairman | 21 |
| Independent Dir/Board Member | 14 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Tomás Dagá Gelabert | 27 |
| Rolf K. Hoffmann | 27 |
| Xiao Ying Gao | 21 |
| David Bell | 21 |
| Bernhard R. M. Ehmer | 16 |
| Gregor Schulz | 16 |
| Uta Kemmerich-Keil | 16 |
| Christoph Schröder | 14 |
| Thorlef Spickschen | 14 |
| Yang Tan | 13 |
| Alessandro Banchi | 9 |
| Simone Fischer | 6 |
| Rolf Vornhagen | 6 |
| Peter Janssen | 5 |
| Thomas Jakob | 5 |
- Börse
- Insiders
- Georg Floß
- Unternehmensverbindungen
